Status:
COMPLETED
Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Central Serous Chorioretinopathy
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the clinical efficacy of an initial subthreshold retinal micropulselasercoagulation versus a single intravitreal 1.5mg bevacizumab injection in central serous ...
Detailed Description
To evaluate the clinical efficacy of an initial subthreshold retinal micropulselasercoagulation in twelve eyey per group versus a single intravitreal 1.5mg bevacizumab injection in central serous chor...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- CSC of \>4 months duration
- Exclusion Criteria:
- History of macular or chorioretinal inflammation
- Lens / corneal opacities
Exclusion
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00802906
Start Date
May 1 2007
End Date
December 1 2010
Last Update
September 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ZAU Department of VR surgery
Frankfurt am Main, Hesse, Germany, 60590